Research Article
Treatment with PPARα Agonist Clofibrate Inhibits the Transcription and Activation of SREBPs and Reduces Triglyceride and Cholesterol Levels in Liver of Broiler Chickens
Table 2
Characteristics and performance data of the primers used for reference gene-stability measure and quantitative real-time PCR analysis.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sterol regulatory element binding transcription factors 1 and 2 (SREBF1 and SREBF2); peroxisome proliferator-activated receptor alpha (PPARα); carnitine palmitoyltransferase 1A (CTP1A); fatty acid synthase (FASN); glycerol-3-phosphate acyltransferase, mitochondrial (GPAM); 3-hydroxy-3-methylglutaryl CoA reductase (HMGCR), low-density lipoprotein receptor (LDLR); Liver X-Receptor alpha (LXRα); insulin induced genes 1 and 2 (INSIG1 and INSIG2); ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide (ATP5B); topoisomerase (DNA) I (TOP1); malate dehydrogenase 1, NAD (soluble) (MDH1); ribosomal protein L13 (RPL13); tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide (YWHAZ); glyceraldehyde-3-phosphate dehydrogenase (GAPDH). |